Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9865617rdf:typepubmed:Citationlld:pubmed
pubmed-article:9865617lifeskim:mentionsumls-concept:C0005855lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0035334lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0271051lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0000981lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0060520lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0005529lld:lifeskim
pubmed-article:9865617lifeskim:mentionsumls-concept:C0231242lld:lifeskim
pubmed-article:9865617pubmed:issue12lld:pubmed
pubmed-article:9865617pubmed:dateCreated1999-3-16lld:pubmed
pubmed-article:9865617pubmed:abstractTextThe carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa. To better understand the oedema-reducing effect of AZM, the effect of AZM on passive permeability and active transport of fluorescein across the blood-retina barrier was studied in patients with retinitis pigmentosa and varying degrees of macular oedema.lld:pubmed
pubmed-article:9865617pubmed:languageenglld:pubmed
pubmed-article:9865617pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:citationSubsetIMlld:pubmed
pubmed-article:9865617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9865617pubmed:statusMEDLINElld:pubmed
pubmed-article:9865617pubmed:monthDeclld:pubmed
pubmed-article:9865617pubmed:issn0721-832Xlld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:LarsenMMlld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:RosenbergTTlld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:EnglerCClld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:Lund-Andersen...lld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:MICClld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:SanderBBlld:pubmed
pubmed-article:9865617pubmed:authorpubmed-author:MoldowBBlld:pubmed
pubmed-article:9865617pubmed:issnTypePrintlld:pubmed
pubmed-article:9865617pubmed:volume236lld:pubmed
pubmed-article:9865617pubmed:ownerNLMlld:pubmed
pubmed-article:9865617pubmed:authorsCompleteYlld:pubmed
pubmed-article:9865617pubmed:pagination881-9lld:pubmed
pubmed-article:9865617pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:meshHeadingpubmed-meshheading:9865617-...lld:pubmed
pubmed-article:9865617pubmed:year1998lld:pubmed
pubmed-article:9865617pubmed:articleTitleThe effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.lld:pubmed
pubmed-article:9865617pubmed:affiliationUniversity of Copenhagen, Herlev Sygehus, Department of Ophthalmology, Denmark.lld:pubmed
pubmed-article:9865617pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9865617pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9865617pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9865617pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9865617pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9865617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9865617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9865617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9865617lld:pubmed